Onconetix, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ONCO on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 E. Fifth Street, Suite 1900, Cincinnati, OH

There are no Buy or Sell transactions made by insiders since 12/23/2023

Onconetix, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Hernandez CEO, Director, 10%+ Owner $11.5M May 9, 2023
Cincinnati Cornerstone Investors BWV I, LLC 10%+ Owner $4.76M Apr 10, 2023
Ralph Schiess Interim CEO & CSO $1.11M Sep 24, 2024
Christian Bruhlmann Chief Strategy Officer $969K Sep 24, 2024
Erin Henderson Chief Business Officer $717K May 9, 2023
Jon Garfield Chief Financial Officer $410K May 9, 2023
Vuk Jeremic Director $26.1K May 31, 2023
James Sapirstein Director $26.1K Sep 26, 2024
Timothy Ramdeen Director $26.1K Sep 26, 2024
Simon Tarsh Director $26.1K Sep 26, 2024
Neil Campbell Chief Executive Officer, Director Oct 4, 2023
Bruce Harmon Chief Financial Officer Oct 4, 2023
Allan Shaw Director Aug 19, 2022
Michael Venerable Director May 4, 2022
Kimberly Murphy Director May 4, 2022
John McCune Rice Jr. Director Feb 17, 2022
Karina M. Fedasz Interim CFO Jun 10, 2024
Ajit Singh Director Sep 26, 2024
Thomas Meier Director Sep 26, 2024
Altos Venture AG 10%+ Owner Sep 24, 2024

Recent Insider Transactions by Companies or Individuals for Onconetix, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.